Inventor · disambiguated record
Abdelmalik Slassi
Also filed as: SLASSI ABDELMALIK
57 granted patents·73 pending applications·802 citations·filing 1994–2025
98Inventor score
Files withASTRAZENECA AB42MINDSET PHARMA INC20NPS PHARMA INC15NPS ALLELIX CORP12TRILLIUM THERAPEUTICS INC11
Top patents by PatentIndex Score
130 records- 0198US6660753B2Heteropolycyclic compounds and their use as metabotropic glutamate receptor antagonistsNPS PHARMA INC·Filed 2002·Granted Dec 9, 2003·160 cites·58 claims
- 0297US11591353B2Psilocin derivatives as serotonergic psychedelic agents for the treatment of CNS disordersMINDSET PHARMA INC·Filed 2022·Granted Feb 28, 2023·9 cites·15 claims
- 0396US11597738B2Psilocin derivatives as serotonergic psychedelic agents for the treatment of CNS disordersMINDSET PHARMA INC·Filed 2022·Granted Mar 7, 2023·4 cites·29 claims
- 0496US11427604B2Psilocin derivatives as serotonergic psychedelic agents for the treatment of CNS disordersMINDSET PHARMA INC·Filed 2021·Granted Aug 30, 2022·4 cites·30 claims
- 0596US7112595B2Heteropolycyclic compounds and their use as metabotropic glutamate receptor antagonistsASTRAZENECA AB·Filed 2003·Granted Sep 26, 2006·92 cites·23 claims
- 0693US7585881B2Additional heteropolycyclic compounds and their use as metabotropic glutamate receptor antagonistsASTRAZENECA AB·Filed 2005·Granted Sep 8, 2009·36 cites·2 claims
- 0793US7485722B2Spiro-oxazolidinone compounds and their use as metabotropic glutamate receptor potentiatorsASTRAZENECA AB·Filed 2007·Granted Feb 3, 2009·29 cites·13 claims
- 0889US12378266B2Psilocin derivatives as serotonergic psychedelic agents for the treatment of CNS disordersMINDSET PHARMA INC·Filed 2024·Granted Aug 5, 2025·0 cites·45 claims
- 0989US12054504B23-pyrrolidine-indole derivatives as serotonergic psychedelic agents for the treatment of CNS disordersMINDSET PHARMA INC·Filed 2022·Granted Aug 6, 2024·1 cites·17 claims
- 1089US6686374B1Azaindoles having serotonin receptor affinityNPS ALLELIX CORP·Filed 2000·Granted Feb 3, 2004·24 cites·10 claims
- 1188US7799792B2Metabotropic glutamate receptor oxadiazole ligands and their use as potentiators 841ASTRAZENECA AB·Filed 2008·Granted Sep 21, 2010·11 cites·14 claims
- 1288US5998438A5-cyclo indole compoundsALLELIX BIOPHARMA·Filed 1997·Granted Dec 7, 1999·49 cites·40 claims
- 1388US2025388611A1Psilocin derivatives as serotonergic psychedelic agents for the treatment of cns disordersMINDSET PHARMA INC·Filed 2024·Application pending·0 cites
- 1487US7960422B2Pharmaceutically active compounds containing tetrazolyl and triazolyl ringsASTRAZENECA AB·Filed 2008·Granted Jun 14, 2011·11 cites·2 claims
- 1586US7868008B2Substituted isoindolones and their use as metabotropic glutamate receptor potentiatorsASTRAZENECA AB·Filed 2006·Granted Jan 11, 2011·11 cites·4 claims
- 1686US6133287APiperidine-indole compounds having 5-HT6 affinityALLELIX BIOPHARMA·Filed 1998·Granted Oct 17, 2000·38 cites·19 claims
- 1785US7476684B2Compounds for the treatment of neurological, psychiatric or pain disordersASTRAZENECA AB·Filed 2006·Granted Jan 13, 2009·11 cites·5 claims
- 1885US7268127B2Azaindoles having serotonin receptor affinityNPS ALLELIX CORP·Filed 2005·Granted Sep 11, 2007·5 cites·7 claims
- 1985US5856510A5-alkenyl and 5-alkynyl indole compoundsALLELIX BIOPHARMA·Filed 1996·Granted Jan 5, 1999·38 cites·30 claims
- 2083US10259809B2Fluorinated imidazo[4,5-C]quinoline derivatives as inhibitors of bromodomain containing proteinsTRILLIUM THERAPEUTICS INC·Filed 2016·Granted Apr 16, 2019·2 cites·24 claims
- 2183US7074809B2CompoundsNPS PHARMA INC·Filed 2003·Granted Jul 11, 2006·23 cites·12 claims
- 2283US6916818B2Azaindoles having serotonin receptor affinityNPS ALLELIX CORP·Filed 2003·Granted Jul 12, 2005·12 cites·5 claims
- 2383US6635639B2Use of N-alkylamino-heterocylic compounds for the treatment of migraineNPS ALLELIX CORP·Filed 2002·Granted Oct 21, 2003·20 cites·15 claims
- 2483US6251893B1Bicyclic piperidine and piperazine compounds having 5-HT6 receptor affinityNPS ALLELIX CORP·Filed 1998·Granted Jun 26, 2001·68 cites·30 claims
- 2582US12054505B2Psilocin derivatives as serotonergic psychedelic agents for the treatment of CNS disordersMINDSET PHARMA INC·Filed 2022·Granted Aug 6, 2024·0 cites·21 claims
- 2682US7807706B2Metabotropic glutamate-receptor-potentiating isoindolonesASTRAZENECA AB·Filed 2006·Granted Oct 5, 2010·6 cites·9 claims
- 2782US7456200B2CompoundsASTRAZENECA AB·Filed 2005·Granted Nov 25, 2008·9 cites·11 claims
- 2882US2023167141A1Psilocin derivatives as serotonergic psychedelic agents for the treatment of cns disordersMINDSET PHARMA INC·Filed 2023·Application pending·0 cites
- 2981US8377940B2Oxadiazole derivatives and their use as metabotropic glutamate receptor potentiators—842ASTRAZENECA AB·Filed 2008·Granted Feb 19, 2013·4 cites·13 claims
- 3081US7968570B2Isoindolone compounds and their use as metabotropic glutamate receptor potentiatorsASTRAZENECA AB·Filed 2005·Granted Jun 28, 2011·6 cites·4 claims
- 3181US6897215B1Compounds having 5-HT6 receptor antagonist activityNPS ALLELIX CORP·Filed 2000·Granted May 24, 2005·11 cites·23 claims
- 3280US2023203070A1Psilocin derivatives as serotonergic psychedelic agents for the treatment of cns disordersMINDSET PHARMA INC·Filed 2023·Application pending·0 cites
- 3378US6100291APyrrolidine-indole compounds having 5-HT6 affinityALLELIX BIOPHARMA·Filed 1998·Granted Aug 8, 2000·23 cites·23 claims
- 3477US2024336641A13-pyrrolidine-indole derivatives as serotonergic psychedelic agents for the treatment of cns disordersMINDSET PHARMA INC·Filed 2024·Application pending·0 cites
- 3576US6716837B1Heterocyclic compounds for the treatment of migraineNPS ALLELIX BIOPHARMACEUTICALS·Filed 2000·Granted Apr 6, 2004·13 cites·20 claims
- 3675US7772235B2mGluR5 modulatorsASTRAZENECA AB·Filed 2007·Granted Aug 10, 2010·2 cites·6 claims
- 3774US8148394B2Azaindoles having serotonin receptor affinityEDWARDS LOUISE·Filed 2007·Granted Apr 3, 2012·2 cites·16 claims
- 3874US7678796B2MGluR5 modulators IASTRAZENECA AB·Filed 2007·Granted Mar 16, 2010·3 cites·21 claims
- 3973US2025034106A13-cycloamino-indole compounds as serotonergic agents useful for the treatment of disorders related theretoMINDSET PHARMA INC·Filed 2022·Application pending·0 cites
- 4072US11453689B23-pyrrolidine-indole derivatives as serotonergic psychedelic agents for the treatment of CNS disordersMINDSET PHARMA INC·Filed 2021·Granted Sep 27, 2022·0 cites·28 claims
- 4172US9441012B2Fluorinated epoxyketone-based compounds and uses thereof as proteasome inhibitorsFLUORINOV PHARMA INC·Filed 2013·Granted Sep 13, 2016·3 cites·30 claims
- 4272US7576077B2Fused heterocyclic compounds and their use as metabotropic glutamate receptor antagonistsASTRAZENECA AB·Filed 2005·Granted Aug 18, 2009·2 cites·16 claims
- 4371US7935703B2Piperazines and piperidines as Mglur5 potentiatorsASTRAZENECA AB·Filed 2007·Granted May 3, 2011·1 cites·2 claims
- 4471US2025353827A1Indoline derivatives as serotonergic agents useful for the treatment of disorders related theretoMINDSET PHARMA INC·Filed 2023·Application pending·0 cites
- 4570US2024376052A1N-substituted indole derivatives as serotonergic agents useful for the treatment of disorders related theretoMINDSET PHARMA INC·Filed 2022·Application pending·0 cites
- 4670US2024383850A1Indole derivatives as serotonergic agents useful for the treatment of disorders related theretoMINDSET PHARMA INC·Filed 2022·Application pending·0 cites
- 4768US6191141B1Azaindoles having serotonin receptor affinityNPS ALLELIX CORP·Filed 1999·Granted Feb 20, 2001·26 cites·8 claims
- 4867US2025257034A1Indole derivatives as serotonergic agents useful for the treatment of disorders related theretoMINDSET PHARMA INC·Filed 2025·Application pending·0 cites
- 4965US5627194AAnti-viral guanidino-substituted compoundsALLELIX BIOPHARMA·Filed 1994·Granted May 6, 1997·8 cites·19 claims
- 5064US10696670B2Fluorinated imidazo[4,5-C]quinoline derivatives as inhibitors of bromodomain containing proteinsTRILLIUM THERAPEUTICS INC·Filed 2019·Granted Jun 30, 2020·0 cites·18 claims
Showing the top 50 of 130 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Abdelmalik Slassi files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →